- AU$233.40m
- AU$306.67m
- AU$214.03m
- 83
- 42
- 84
- 77
Annual cashflow statement for Probiotec, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.146 | 0 | — | — | — |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.39 | 10.2 | 24.4 | 19.5 | 17.2 |
| Capital Expenditures | -12.5 | -5.63 | -4.19 | -6.93 | -10.1 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 42.6 | -19.3 | -31.7 | -9.54 | -3.59 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Cash from Investing Activities | 30.1 | -25 | -35.9 | -16.5 | -13.7 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -18.6 | 12.2 | 33.6 | -9.27 | -11.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.03 | -2.54 | 22.1 | -6.22 | -8.15 |